Clinical Trials Logo

Pleural Diseases clinical trials

View clinical trials related to Pleural Diseases.

Filter by:

NCT ID: NCT03468933 Completed - Pleural Diseases Clinical Trials

Fibrinolysis Compared to Thoracoscopy for Pleural Infection

Start date: November 1, 2017
Phase: Phase 4
Study type: Interventional

The purpose of this prospective randomized clinical trial is to compare two currently accepted standard-of-care treatment strategies: Medical thoracoscopy as compared to instillation of intrapleural tissue Plasminogen Activator (TPA) and human recombinant Deoxyribonuclease (DNase) for the management of empyema or complicated parapneumonic effusion (CPPE) in adults.

NCT ID: NCT03325192 Terminated - Clinical trials for Pleural Effusion, Malignant

Rapid Pleurodesis Through an Indwelling Pleural Catheter

RAPID
Start date: December 12, 2017
Phase: N/A
Study type: Interventional

The primary objective of the study is to evaluate whether the use of a rapid pleurodesis protocol using 10% iodopovidone immediately after tunneled pleural catheter placement improves time to IPC removal compared to patients who receive an IPC alone.

NCT ID: NCT03290183 Recruiting - Thymoma Clinical Trials

Confocal Laser Endomicroscopy in Pleural Malignancies

Start date: August 28, 2017
Phase: N/A
Study type: Observational

To date, the different biopsy methods, such as CT-guided pleural biopsy, mediastinal biopsy, endosonography and thoracoscopy have their limitations in diagnosing pleural malignancies, such as mesothelioma. Sampling errors frequently occur resulting in the common histological finding of 'non-specific pleuritic/fibrosis', which presents a great uncertainty for clinicians and patients. Confocal laser endomicroscopy (CLE) provides real-time imaging on a cellular level, however data of CLE in pleural malignancies are lacking.

NCT ID: NCT03213834 Completed - Pleural Diseases Clinical Trials

Fibrinolytic Therapy Versus Medical Thoracoscopy

Start date: September 14, 2017
Phase: Phase 4
Study type: Interventional

The purpose of this prospective randomized clinical trial is to compare two currently accepted standard-of-care treatment strategies: medical thoracoscopy as compared to instillation of intrapleural tissue plasminogen activator (TPA) and human recombinant deoxyribonuclease (DNase) for the management of complicated pleural infections in adults as defined as complicated parapneumonic effusions or pleural empyema.

NCT ID: NCT03172585 Not yet recruiting - Pleural Diseases Clinical Trials

Transthoracic Sonography Versus High Resolution Computed Tomography in Alveolar Intersitial Syndrome

Start date: June 2017
Phase: N/A
Study type: Interventional

High resolution computed tomography of the chest is the gold standard imaging modality for most pulmonary diseases. However, the associated high expenses, radiation exposure , and its limited possibility for bedside use are a limitation.

NCT ID: NCT03153501 Completed - Clinical trials for Medical Thoracoscopy

Efficiency and Safety of Pleural Biopsy Methods in the Diagnosis of Pleural Diseases

Start date: February 8, 2011
Phase: N/A
Study type: Interventional

Image-guided pleural biopsies, both ultrasound (US) or computed tomography (CT) guided, and medical thoracoscopy are important in the diagnosis of pleural disease. However, no consensus exists regarding which biopsy methods are appropriate for specific procedures. In this prospective study, the investigators aimed to compare CT-scan guided pleural biopsy using an Abrams' needle (CT-ANPB) with US-assisted pleural biopsy using a cutting needle (US-CNPB)and medical thoracoscopy with respect to both diagnostic yield and safety.

NCT ID: NCT02973139 Completed - Pleural Diseases Clinical Trials

Fibrinolysis Compared to Thoracoscopy for Pleural Infection

Start date: July 14, 2017
Phase: N/A
Study type: Interventional

The purpose of this prospective randomized clinical trial is to compare two currently accepted standard-of-care treatment strategies: Medical thoracoscopy as compared to instillation of intrapleural tissue Plasminogen Activator (TPA) and human recombinant Deoxyribonuclease (DNase) for the management of empyema or complex parapneumonic effusion (CPPE) in adults.

NCT ID: NCT02891642 Recruiting - Pleural Effusion Clinical Trials

Liquid Biopsy With Immunomagnetic Beads Capture Technique for Malignant Cell Detection in Body Fluid

Start date: September 2016
Phase:
Study type: Observational

The purpose of the current study is to establish a Liquid biopsy method (positive enrichment by a novel immunomagnetic beads capture assay) for detection of malignant cell in serous effusions and to evaluate its sensitivity and specificity for clinical application.

NCT ID: NCT02866305 Recruiting - Clinical trials for Primary Spontaneous Pneumothorax

Study Designed to Optimize the Treatment of Primary Pneumothorax

TOPP
Start date: March 2009
Phase: Phase 0
Study type: Interventional

Knowledge about incidence, risk factors and genetic predispositions of primary spontaneous pneumothorax in young adults is very limited, and treatment has also been controversial.The Aim of this study is to optimize the treatment, estimate the actual incidence, and identify possible risk factors including genetic predispositions.

NCT ID: NCT02633332 Completed - Clinical trials for Rheumatoid Arthritis

Use of Well Known Drugs for New Destination - RA Improvement (RANT)

RANT
Start date: February 2015
Phase: Phase 1
Study type: Interventional

The purpose of this interventional study is to determine whether tetracyclines, statins, antiviral and Vitamin D3 in single subministration are effective in improvement of life and health condition in the treatment of rheumatoid arthritis due to autoimmune disease (RA) in all his forms, specially in patients intolerant to commonly used treatments.